View of Comparative effectiveness of tislelizumab versus pembrolizumab as monotherapy in transplant-ineligible adult relapsed/refractory classical Hodgkin lymphoma: a systematic review

Return to Article Details Comparative effectiveness of tislelizumab versus pembrolizumab as monotherapy in transplant-ineligible adult relapsed/refractory classical Hodgkin lymphoma: a systematic review Download Download PDF